Condition

Multiple Myeloma and Malignant Plasma Cell Neoplasms clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• BCMA PET/CT to visualize myeloma and related plasma cell disorders

  A multicenter study tests whether 68Ga-BCMA PET/CT can noninvasively detect active multiple myeloma and related diseases in patients.

  Recruiting at 5 sites Phase 2/3 Peking University First Hospital · Beijing, Beijing Municipality and 4 other locations · NCT07319897

• BCMA-targeted PET imaging probe for diagnosing multiple myeloma.

  We will test a new 68Ga-labeled BCMA-targeted PET probe (68Ga-MM-BC1) to see if it detects multiple myeloma more accurately in people suspected of or diagnosed with the disease.

  Recruiting Early Phase 1 Peking University First Hospital · Beijing, Beijing Municipality and 1 other locations · NCT06717113

Related topics

Quick answers

How many Multiple Myeloma and Malignant Plasma Cell Neoplasms clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Early Phase 1: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →